We are live on
!
Find out more
OHCM
Orchard Hill Capital Management Portfolio holdings
AUM
$22.6M
1-Year Est. Return
3.52%
This Fund
S&P 500
This Quarter
Est. Return
+0.13%
1 Year Est. Return
-3.52%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.95B
AUM Growth
-$47.2M
(-2.4%)
Cap. Flow
-$1.72B
Cap. Flow
% of AUM
-88.57%
Top 10 Holdings %
Top 10 Hldgs %
93.27%
Holding
29
New
1
Increased
4
Reduced
1
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Supernus Pharmaceuticals
SUPN
|
+$9.68M |
| 2 |
GM.WS.B
General Motors Company
GM.WS.B
|
+$3.05M |
| 3 |
Lam Research
LRCX
|
+$63.1K |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 0.56% |
| 2 | Technology | 0.02% |
Similar funds
AC
WA
ACM
ADICC
SC
3NC
IT
BR
Orchard Hill Capital Management's Q4 2013 Portfolio in Review
As of Q4 2013, Orchard Hill Capital Management held 29 positions worth $1.95B, down 2.4% from $1.99B the previous quarter. Its ten largest holdings account for 93% of the portfolio.
Orchard Hill Capital Management withdrew a net $1.72B in Q4 2013, closing 2 positions and reducing 1 holding.
By sector, the portfolio is most concentrated in Healthcare at 0.56% of assets, up from 0.02% a quarter earlier, followed by Technology.
Against the trend, Orchard Hill Capital Management added an estimated $9.68M to Supernus Pharmaceuticals.
- Orchard Hill Capital Management added most to Supernus Pharmaceuticals in Q4 2013, an estimated $9.68M increase.
- Orchard Hill Capital Management's ten largest holdings make up 93% of its $1.95B portfolio in Q4 2013.
- Orchard Hill Capital Management opened 1 new position and closed 2 in Q4 2013.
- Orchard Hill Capital Management's portfolio value fell 2.4% quarter-over-quarter to $1.95B.
Based on Orchard Hill Capital Management's 13F filing for Q4 2013, filed 14 Feb 2014.